Our Company

Our Company

Corporate Responsibility

Corporate Responsibility

Disclosures

Leadership

Derived from the expression 'securing health for all of us', Seqirus has public health protection at its core.
Learn more

At Seqirus, Corporate Responsibility is about conducting our business ethically and contributing to the economic, social and environmental well-being of our communities.
Learn more
Expertise

Expertise

Influenza

Influenza

Pandemic Response Solutions

Antivenom & Q fever Vaccines

Antivenom & Q fever Vaccines

Australian Bites and Stings

In-licensing

Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention of influenza globally, with extensive research and production expertise and manufacturing plants in the US, UK and Australia.
Learn more

Seqirus is on the front line of battling influenza, working hard to suppress costly and life-threatening epidemics and pandemics. Vaccination is the most effective way to prevent influenza .
Learn more
R&D

R&D

Research Practices

Investigator Initiated Studies

Our Seqirus research and development group provides support to ensure the conditions are optimised for efficient vaccine manufacture. Activities also focus on improving the effectiveness of current influenza vaccines and their manufacturing processes.
Learn more

At Seqirus, we are committed to carrying out R&D in an ethical and transparent way as well as in accordance with government regulations and industry codes for good practice.
Learn more
Manufacturing

Manufacturing

Global Manufacturing Network

Technologies

Technical Development

Quality & Safety

One of the largest influenza vaccine companies in the world, Seqirus operates state-of-the-art manufacturing facilities in three different continents and a globally integrated supply chain for the timely supply of influenza vaccine to customers around the world.
Learn more

Seqirus utilises both egg and cell-based production technologies and we offer a broadest portfolio of influenza vaccines. We have commercialised the only adjuvanted seasonal influenza vaccine for older adults and paediatrics and offer two different types of quadrivalent influenza vaccines.
Learn more
Products
Championing Change
Careers

Careers

Graduate Program

See Yourself at Seqirus

Discover Our People

Diversity and Inclusion

How we care for you at Seqirus

When you join Seqirus, you join a team dedicated to protecting people and communities from influenza. It's a feeling of purpose and possibility that inspires us every day.
Learn more

It doesn't matter whether you are a scientist or an administrator, a marketer or an operator - as long as you are inspired by the chance to create something that will help others, you can find your role at Seqirus.
Learn more

Our Company
- Corporate Responsibility
Expertise
- Influenza
- Antivenom & Q fever Vaccines
R&D
Manufacturing
Careers

Seqirus Parkville

CONTACT

Contact Us

Our Australian headquarters are in Parkville, Victoria.

Thank you for your interest in Seqirus. We care about your questions and concerns. You can find the best way to contact us from the list below.

contact person

Customer Service

Customer Service Enquiries for vaccines, antivenoms and in-licensed pharmaceuticals

Within Australia phone: 1800 008 275
Email: customer.service.au@seqirus.com

Seqirus Australia

63 Poplar Road, Parkville, Victoria 3052
Ph: +61 3 9389 2000
Fax: +61 3 9389 1434

Medical Information

Please contact our Medical Information team for product enquiries, from 9:00 am to 5:00 pm AEST (Mon to Fri)

Within Australia phone: 1800 642 865

CSL Direct

CSL Direct provides a convenient ordering portal for Seqirus products and vaccines.
Visit the CSL Direct website.

If you would like more information about CSL direct, please contact CSL customer service on 1800 008 275.

Report an adverse event →
For media →
Partnerships →
Worldwide directory →

global contact

Global Headquarters

Seqirus UK Limited
Point, Level 3, 29 Market Street
Maidenhead SL6 8AA
United Kingdom
Phone: +44 (0) 1628 641500

Corporate Enquiries UK
Email: info.uk@seqirus.com

SEQ/CORP/1019/0027 October 2019